Dr. Laura Huppert is an Assistant Professor and breast medical oncologist at the University of California, San Francisco (UCSF). Dr. Huppert earned her medical degree at Harvard Medical School. She completed Internal Medicine Residency and Hematology/Oncology Fellowship at UCSF before starting on faculty at UCSF. Dr. Huppert is interested in clinical trials with novel agents in the early-stage and metastatic setting. She is the UCSF site PI of the Translational Breast Cancer Research Consortium (TBCRC) and is the PI of a multisite prospective antibody-drug conjugate sequencing registry through the TBCRC. Dr. Huppert is also an active member of the ISPY2 Trial Consortium; she leads the ISPY Metastatic and Central Nervous System (CNS) Working Groups and Co-Chairs the ISPY Safety Working Group for the Endocrine Optimization and DCIS trials.